VC
Value Add VC
⚡HomePulse⚡Helpful Apps📝Blog🤝Partner
Illustration for: Barclays Declares a 'Golden Age' for Tech IPOs
Value Add VC/Pulse/IPO

Barclays Declares a 'Golden Age' for Tech IPOs

Barclays' head of TMT equity capital markets called the current market a 'golden age' for tech IPOs, citing overlapping boom cycles across AI, power infrastructure, robotics, defense tech and space with capacity to absorb far more listings.

By the Numbers

$2.1T
IPO pipeline value
$129.3B
H1 2026 raised
44.5%
Avg first-day gain
Jul 22, 2026
Commentary date
TC
Trace Cohen
Early-stage VC & angel · Founder, New York Venture Partners
July 22, 2026
1 min read
ShareXLinkedInEmail

THE RUNDOWN

1

Jamie Turturici, Barclays' head of TMT equity capital markets, said on Bloomberg TV on July 22 that the tech IPO market is entering 'a golden age,' citing rare overlapping innovation cycles across AI, power infrastructure, data centers, robotics, automation, defense tech and space

2

The tech IPO pipeline carries a reported $2.1 trillion cumulative valuation as of July 2026, with Nasdaq reporting $129.3 billion raised from new listings in the first half of the year and technology IPOs averaging a 44.5% first-day gain per S&P Global

3

Turturici argued there is 'plenty of market capacity to absorb' the wave of companies heading toward public markets, a notably more bullish framing than the market-absorption concerns that dogged the 2021 SPAC-era IPO boom

4

The commentary lands the same week SpaceX approaches its first major post-IPO share unlock while trading well below its debut high -- a live reminder that 'golden age' enthusiasm and actual aftermarket performance for individual names can diverge sharply

TC

The VC Read · Trace's Take

Trace Cohen

'Plenty of capacity to absorb IPOs' is exactly what bankers said in 2021 right before the pipeline broke. The categories underneath this cycle -- AI, power, robotics, defense, space -- are genuinely more diverse than 2021's single-theme boom, which is the real bull case. But SpaceX trading below its debut high with a share unlock coming, in the same news cycle as this 'golden age' call, is the tension every LP should sit with before getting too excited about exit timing.

Tech IPO Tracker →

Analysis

Jamie Turturici, Barclays' head of TMT equity capital markets, declared on Bloomberg TV on July 22 that the technology IPO market is entering 'a golden age,' pointing to a rare overlap of innovation cycles across AI, power infrastructure, data centers, robotics, automation, defense tech and space all pushing companies toward public markets simultaneously.

The numbers back up the bullish framing, at least in aggregate: the tech IPO pipeline carries a reported $2.1 trillion cumulative valuation as of July 2026, Nasdaq reported $129.3 billion raised from new listings in the first half of the year, and S&P Global found technology IPOs delivered an average first-day gain of 44.5% over the same period -- all well above historical norms for a healthy, non-bubble IPO market.

“Her framing is that this cycle is different because the underlying businesses span multiple genuinely distinct innovation categories rather than one overheated theme.”

Turturici's specific claim -- that there is 'plenty of market capacity to absorb' this wave of listings -- is a direct answer to the concern that killed enthusiasm after the 2021 SPAC-era IPO boom, when too many mediocre companies went public too fast and investor appetite ran out well before the pipeline did. Her framing is that this cycle is different because the underlying businesses span multiple genuinely distinct innovation categories rather than one overheated theme.

The bear case sits right next to the bullish headline, though: SpaceX -- the reference case for this entire 'golden age' narrative -- is trading well below its post-IPO high and approaching its first major post-lockup share unlock, an event that has hammered plenty of newly public mega-caps before. For VCs and LPs weighing exit timing, Turturici's macro optimism about pipeline capacity doesn't guarantee any single company's aftermarket performance, and the SpaceX case sitting directly alongside the golden-age framing is the clearest evidence of that gap.

ShareXLinkedInEmail

Reported by Bloomberg · Analysis by Value Add Pulse.

← Back to Pulse

THE WIRE in your inbox— Tech, startup & VC news with Trace's take. Free, no spam.

Read Next

IPO· Aug 9, 2026

What BofA's Extreme Bull Signal Means for Your Marks

Illustration for: What BofA's Extreme Bull Signal Means for Your Marks
IPO

What BofA's Extreme Bull Signal Means for Your Marks

BofA's Bull & Bear indicator hit 9.7, its highest since 2021 and above the firm's own 8.0 sell threshold — a trace's-take on what that extreme reading should change about how GPs mark portfolio companies against public comps.

IPO· Aug 8, 2026

Biotech IPOs Are Pricing Above Range Again

Illustration for: Biotech IPOs Are Pricing Above Range Again
IPO$532.5M combined

Biotech IPOs Are Pricing Above Range Again

BlossomHill and Braveheart Bio both upsized and priced above their original ranges this week, the clearest two-deal signal yet that the biotech IPO window -- closed to all but the strongest names in 2024-2025 -- is reopening.

IPO· Aug 7, 2026

BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq

Illustration for: BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq
IPO$150M IPO

BlossomHill Prices Upsized $150M IPO, Debuts on Nasdaq

BlossomHill Therapeutics priced an upsized IPO at $16 a share for $150M and began trading on Nasdaq under BLSM, more than 50% above the $100M target Pulse flagged when the company first filed.

@Trace_Cohen·t@nyvp.com